Timing of Therapies
Our predecessor site BCCT summarizes the evidence regarding the effects of timing of therapies with cancer.
. Last modified on : Nov 17 2022Statins
Our predecessor site BCCT summarizes the evidence regarding statins’ effects with cancer.
. Last modified on : Nov 17 2022Propranolol and Other Beta Blockers
Our predecessor site BCCT summarizes the evidence regarding propranolol’s and other beta blockers’ effects with cancer.
. Last modified on : Nov 17 2022Non-aspirin Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
Nonsteroidal anti-inflammatory drugs (NSAIDs) are used to reduce inflammation, with notable benefits in increasing survival and reducing risk of several types of cancer; expert consensus is that the risks of harm from using these drugs long-term for prevention are greater than the benefits for many people.
. Last modified on : Oct 25 2022Metformin
Our predecessor site BCCT summarizes the evidence regarding metformin’s off-label effects with cancer.
. Last modified on : Nov 17 2022Low-dose Naltrexone
This prescription drug is used off-label in low doses to treat people with cancer, with notable but very preliminary successes in cases where the cancers were difficult-to-treat or quite advanced.
. Last modified on : Oct 25 2022Hyperthermia
Our predecessor site BCCT summarizes the evidence regarding hyperthermia’s effects with cancer.
. Last modified on : Nov 17 2022Copper Chelation
Copper promotes the formation of blood vessels, including those that supply tumors. Depleting copper can deprive the tumor of its suppliers.
. Last modified on : Oct 25 2022Cimetidine
Our predecessor site BCCT summarizes the evidence regarding cimetidine’s off-label effects with cancer.
. Last modified on : Nov 17 2022